北美医用大麻市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型（干燥形式和提取物形式）、应用（疼痛管理、图雷特氏症、阿尔茨海默氏病、偏头痛、抑郁和焦虑、多发性硬化症、癌症等）和分销渠道（零售药房、电子商务等）
No. of Pages: 127 | Report Code: BMIRE00028793 | Category: Life Sciences
No. of Pages: 127 | Report Code: BMIRE00028793 | Category: Life Sciences
北美医用大麻市场分为美国、加拿大和墨西哥。据估计，医用大麻市场在美国占有最大份额。医用大麻市场的增长可归因于探索创新治疗应用的研究和合作不断增加、人们对医用大麻的认识不断提高以及该地区主要参与者的存在。此外，该地区不断增长的老龄化人口也将有利于市场的增长。
北美医用大麻市场细分
北美医用大麻市场分为产品类型、应用、分销渠道和国家。
根据产品类型，北美医用大麻市场分为干燥形式和提取物形式。 2022 年，提取物形式在北美医用大麻市场中占据较大份额。
根据应用，北美医用大麻市场分为疼痛管理、妥瑞氏症、阿尔茨海默病、偏头痛、抑郁症和焦虑症、多发性硬化症、癌症等。 2022年，疼痛管理细分市场在北美医用大麻市场中占据最大份额。
根据分销渠道，北美医用大麻市场分为零售药店、零售药店、零售药店和电子药店。 -商业及其他。 2022年，零售药房领域在北美医用大麻市场中占据最大份额。
按国家划分，北美医用大麻市场分为美国、加拿大、和墨西哥。 2022 年，美国将主导北美医用大麻市场。
Aphria, Inc.; CanaQuest 医疗公司； Canopy Growth 公司；翡翠健康治疗公司； GW 制药公司；马里坎公司； Organigram 控股公司；帕纳夏制药工业有限公司；菲娜控股公司；和 VIVO Cannabis Inc 是北美医用大麻市场的领先公司。
Strategic insights for North America Medical Marijuana involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 7,170.17 Million |
| Market Size by 2028 | US$ 20,760.41 Million |
| Global CAGR (2022 - 2028) | 19.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Medical Marijuana refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Medical Marijuana Market is valued at US$ 7,170.17 Million in 2022, it is projected to reach US$ 20,760.41 Million by 2028.
As per our report North America Medical Marijuana Market, the market size is valued at US$ 7,170.17 Million in 2022, projecting it to reach US$ 20,760.41 Million by 2028. This translates to a CAGR of approximately 19.4% during the forecast period.
The North America Medical Marijuana Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Marijuana Market report:
The North America Medical Marijuana Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Medical Marijuana Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Medical Marijuana Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Medical Marijuana Market
